Skip to main content
. Author manuscript; available in PMC: 2024 Nov 1.
Published in final edited form as: Ann Surg. 2023 Jul 21;278(5):e949–e956. doi: 10.1097/SLA.0000000000006035

Table 1.

Baseline patient characteristics and 30-day postoperative adverse outcomes in patients with and without preoperative COVID-19.

Characteristics No Hx of COVID-19
(N = 349,676), No. (%)
Hx of COVID-19
(N = 37,354), No. (%)
P value
Age, years 63 (52, 72) 61 (49, 70) <0.001
18–29 15166 (4.3%) 1625 (4.4%) <0.001
30–49 60828 (17%) 7734 (21%)
50–64 111160 (32%) 12838 (34%)
65+ 162522 (46%) 15157 (41%)
Sex <0.001
Female 190052 (54%) 20952 (≈56%)
Race and Ethnicity <0.001
Non-Hispanic White 257334 (74%) 25833 (69%)
Smoking Status <0.001
Nonsmoker 304141 (86%) 33151 (89%)
Charlson Comorbidity Index <0.001
0–2 178477 (51%) 17527 (47%)
3+ 171199 (49%) 19827 (53%)
Comorbidities
CKD 22374 (6.4%) 3862 (10%) <0.001
CHF 20816 (6.0%) 3454 (9.2%) <0.001
COPD 21089 (6.0%) 3134 (8.4%) <0.001
Coronary Artery Disease 39221 (11%) 5852 (16%) <0.001
Depression 35956 (10%) 5875 (16%) <0.001
Diabetes 41584 (12%) 7144 (19%) <0.001
GERD 58830 (17%) 9432 (25%) <0.001
Hypertension 100981 (29%) 14669 (39%) <0.001
Liver Disease 5730 (1.6%) 977 (2.6%) <0.001
Obesity 51446 (15%) 8920 (24%) <0.001
Relative Risk of Surgery 0.058
Low Risk 134385 (38%) 14364 (38%)
Medium Risk 166702 (48%) 17642 (47%)
High Risk 48589 (14%) 5348 (14%)
Vaccine Status <0.001
Fully Vaccinated 48441 (14%) 5381 (14%)
Non-Fully Vaccinated 301235 (86%) 31973 (86%)
Pandemic Era <0.001
Alpha 204624 (59%) 9661 (26%)
Delta 61838 (18%) 5942 (16%)
Omicron 83214 (24%) 21751 (58%)

To comply with N3C policy, counts below 20 are displayed as <20 and additional values were skewed by up to 5 in order to render it impossible to back-calculate precise counts in the ‘Missing or Unknown’ category. Hx: history; CKD: chronic kidney disease; CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease; GERD: gastroesophageal reflux disease.